Apyx Medical Corporation logo

Apyx Medical Corporation (APYX)

Market Closed
30 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
4. 12
+0.28
+7.2917%
$
163.88M Market Cap
- P/E Ratio
- Div Yield
75,770 Volume
- Eps
$ 3.84
Previous Close
Investors:
Add Transaction
Day Range
3.78 4.3
Year Range
1.59 5.08
Want to track APYX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

APYX closed today higher at $4.12, an increase of 7.2917% from yesterday's close, completing a monthly increase of 3% or $0.12. Over the past 12 months, APYX stock gained 17.7143%.
APYX is not paying dividends to its shareholders.
The last earnings report, released on May 06, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0378%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

APYX Chart

People also search for

Neumora Therapeutics, Inc.
$ 1.65
0%
Bicycle Therapeutics plc American Depositary Receipt
$ 4.01
+3.886%
Sight Sciences, Inc.
$ 5.26
-1.4981%
Macrogenics Inc.
$ 3.78
+2.9973%
Alx Oncology Holdings Inc.
$ 1.95
+0.2571%
Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript

Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript

Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx Medical (APYX) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.1 per share a year ago.

Zacks | 2 months ago
Apyx Medical Corporation (APYX) Q4 2025 Earnings Call Transcript

Apyx Medical Corporation (APYX) Q4 2025 Earnings Call Transcript

Apyx Medical Corporation (APYX) Q4 2025 Earnings Call Transcript

Seekingalpha | 4 months ago

Apyx Medical Corporation Investors

Name Quantity Cost Value Profit ($) Gain (%)
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
34,778 $124,115.85 $141,546.46 $17,430.61 14.04%
Rekah Franca
Rekah Franca Catalyst Funds Management Pty Ltd.
24,072 $88,826 $99,176.64 $10,350.64 11.65%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
15 $55 $61.05 $6.05 11%
Jeffrey M Bernstein
Jeffrey M Bernstein Silverberg Bernstein Capital Management LLC
1.04M $2.53M $4.44M $1.91M 75.38%

Apyx Medical Corporation (APYX) FAQ

What is the stock price today?

The current price is $4.12.

On which exchange is it traded?

Apyx Medical Corporation is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is APYX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 163.88M.

Has Apyx Medical Corporation ever had a stock split?

No, there has never been a stock split.

Apyx Medical Corporation Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Charles D. Goodwin CEO
NASDAQ (NGS) Exchange
03837C106 CUSIP
US Country
205 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Apyx Medical Corporation stands at the forefront of energy technology within the medical device industry, both in the United States and on an international scale. The company has carved a niche for itself through the design, development, and manufacturing of advanced medical devices. It operates across two main segments: Advanced Energy and Original Equipment Manufacturing (OEM). Initially known as Bovie Medical Corporation, it underwent a rebranding phase to become Apyx Medical Corporation in January 2019. This rebranding marked a significant milestone in the company's evolution since its inception in 1982. Headquartered in Clearwater, Florida, Apyx has continuously expanded its footprint in the medical technology space, underscoring its commitment to innovation and quality healthcare solutions.

Products and Services

  • Helium Plasma Generator

    The flagship technology of Apyx Medical Corporation, the Helium Plasma Generator, revolutionizes the delivery of RF energy and helium plasma. It's meticulously designed for cutting, coagulating, and ablating soft tissue in both open and minimally invasive surgical procedures. This advanced equipment signifies the company's innovative prowess in medical device engineering.

  • Renuvion & J-Plasma

    Under the umbrella of Helium Plasma Technology, Apyx markets its products for different markets under two brands: Renuvion and J-Plasma. Renuvion caters to the cosmetic surgery market, providing state-of-the-art equipment for aesthetic enhancements. Meanwhile, J-Plasma is targeted towards the hospital surgical market, where precision and reliability are paramount. This strategic segmentation allows Apyx to address the unique needs of different market sectors effectively.

  • OEM Solutions

    Apyx doesn't just serve end-users directly; it also engages in the development and manufacturing of OEM generators and related accessories. This segment of their business underscores Apyx's versatility and deep understanding of the medical device landscape. Providing OEM solutions, Apyx showcases its ability to innovate not just for its product line but for other companies seeking to integrate Apyx’s advanced energy solutions into their offerings.

  • Hand Pieces for Surgical Procedures

    Complementing its range of generators, Apyx also specializes in the creation of various hand pieces designed for a wide array of surgical applications, both open and laparoscopic. These hand pieces are a testament to the company’s commitment to offering comprehensive solutions that enhance surgical efficiency and outcomes.

Contact Information

Address: 5115 Ulmerton Road
Phone: 727 384 2323